Capital Markets Day BRAIN Biotech AG: Focus on BEC Technology and its Transformational Potential

3 September 2021, Zwingenberg (Germany) - The biotechnology group BRAIN Biotech AG informed investors about important developments in the company as part of a "Capital Markets Day". The focus was on BEC technology and its potential for the company.